For: | Amorim VB, Parente DB, Paiva FF, Oliveira Neto JA, Miranda AA, Moreira CC, Fernandes FF, Campos CFF, Leite NC, Perez RM, Rodrigues RS. Can gadoxetic acid–enhanced magnetic resonance imaging be used to avoid liver biopsy in patients with nonalcoholic fatty liver disease? World J Hepatol 2020; 12(9): 661-671 [PMID: PMC7522564 DOI: 10.4254/wjh.v12.i9.661] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v12/i9/661.htm |
Number | Citing Articles |
1 |
Jennifer Cathcart, Rachael Barrett, James S. Bowness, Ashis Mukhopadhya, Ruairi Lynch, John F. Dillon. Accuracy of Non‐Invasive Imaging Techniques for the Diagnosis of MASH in Patients With MASLD: A Systematic Review. Liver International 2024; doi: 10.1111/liv.16127
|
2 |
Hsu-Heng Yen, Pei-Yuan Su, Siou-Ping Huang, Lisha Wu, Tsui-Chun Hsu, Ya-Huei Zeng, Yang-Yuan Chen, Wan-Long Chuang. Evaluation of non-alcoholic fatty liver disease in patients with inflammatory bowel disease using controlled attenuation parameter technology: A Taiwanese retrospective cohort study. PLOS ONE 2021; 16(5): e0252286 doi: 10.1371/journal.pone.0252286
|